KMS Medisurgi Ltd
₹ 133
4.98%
13 May
- close price
About
Incorporated in 2016, KMS Medisurgi Ltd operates in the manufacturing of Surgical Equipment.[1]
Key Points
- Market Cap ₹ 43.8 Cr.
- Current Price ₹ 133
- High / Low ₹ 133 / 120
- Stock P/E 175
- Book Value ₹ 25.2
- Dividend Yield 0.04 %
- ROCE 4.87 %
- ROE 3.05 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
Cons
- Stock is trading at 5.27 times its book value
- The company has delivered a poor sales growth of 10.2% over past five years.
- Company has a low return on equity of 5.02% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8.89 | 8.41 | 7.90 | 7.32 | 9.86 | 10.34 | 7.51 | 10.32 | 11.03 | 13.88 | 13.94 | 12.21 | |
| 8.17 | 7.59 | 6.95 | 6.85 | 9.56 | 9.68 | 7.01 | 9.79 | 10.07 | 13.03 | 12.99 | 11.31 | |
| Operating Profit | 0.72 | 0.82 | 0.95 | 0.47 | 0.30 | 0.66 | 0.50 | 0.53 | 0.96 | 0.85 | 0.95 | 0.90 |
| OPM % | 8.10% | 9.75% | 12.03% | 6.42% | 3.04% | 6.38% | 6.66% | 5.14% | 8.70% | 6.12% | 6.81% | 7.37% |
| 0.04 | 0.06 | 0.17 | 0.35 | 0.42 | 0.00 | 0.10 | 0.05 | 0.02 | 0.03 | 0.03 | 0.01 | |
| Interest | 0.27 | 0.24 | 0.27 | 0.19 | 0.09 | 0.07 | 0.03 | 0.00 | 0.00 | 0.02 | 0.10 | 0.11 |
| Depreciation | 0.41 | 0.34 | 0.49 | 0.45 | 0.43 | 0.41 | 0.33 | 0.29 | 0.32 | 0.25 | 0.27 | 0.47 |
| Profit before tax | 0.08 | 0.30 | 0.36 | 0.18 | 0.20 | 0.18 | 0.24 | 0.29 | 0.66 | 0.61 | 0.61 | 0.33 |
| Tax % | 50.00% | 53.33% | 38.89% | 50.00% | 40.00% | 38.89% | 45.83% | 24.14% | 13.64% | 24.59% | 27.87% | 27.27% |
| 0.03 | 0.14 | 0.21 | 0.10 | 0.12 | 0.11 | 0.12 | 0.22 | 0.57 | 0.45 | 0.44 | 0.25 | |
| EPS in Rs | 0.60 | 1.17 | 0.88 | 0.30 | 0.36 | 0.33 | 0.36 | 0.67 | 1.73 | 1.36 | 1.33 | 0.76 |
| Dividend Payout % | 0.00% | 25.71% | 5.71% | 16.50% | 13.75% | 15.00% | 13.75% | 7.50% | 2.89% | 3.67% | 3.75% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 10% |
| 3 Years: | 3% |
| TTM: | -12% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 16% |
| 3 Years: | -24% |
| TTM: | -43% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 31% |
| 3 Years: | 14% |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 5% |
| 3 Years: | 5% |
| Last Year: | 3% |
Balance Sheet
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.50 | 1.20 | 2.40 | 3.30 | 3.30 | 3.30 | 3.30 | 3.30 | 3.30 | 3.30 | 3.30 | 3.30 |
| Reserves | 0.64 | 2.13 | 1.12 | 2.85 | 2.95 | 3.05 | 3.15 | 3.37 | 3.93 | 4.36 | 4.79 | 5.01 |
| 2.85 | 2.13 | 2.73 | 1.91 | 1.13 | 1.11 | 1.03 | 0.99 | 0.99 | 0.54 | 0.91 | 0.77 | |
| 3.21 | 2.60 | 2.36 | 2.14 | 3.15 | 1.64 | 1.86 | 2.17 | 1.51 | 2.65 | 1.34 | 1.47 | |
| Total Liabilities | 7.20 | 8.06 | 8.61 | 10.20 | 10.53 | 9.10 | 9.34 | 9.83 | 9.73 | 10.85 | 10.34 | 10.55 |
| 2.25 | 1.98 | 2.69 | 2.25 | 2.20 | 1.81 | 1.65 | 1.48 | 1.82 | 1.65 | 1.68 | 2.93 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 4.95 | 6.08 | 5.92 | 7.95 | 8.33 | 7.29 | 7.69 | 8.35 | 7.91 | 9.20 | 8.66 | 7.62 | |
| Total Assets | 7.20 | 8.06 | 8.61 | 10.20 | 10.53 | 9.10 | 9.34 | 9.83 | 9.73 | 10.85 | 10.34 | 10.55 |
Cash Flows
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.35 | -0.24 | 0.90 | -1.57 | 0.75 | -0.84 | 0.53 | -0.07 | 0.46 | 1.21 | 0.74 | 1.51 | |
| 0.05 | -0.03 | -1.10 | 0.11 | -0.31 | 0.01 | -0.10 | -0.12 | -0.66 | -0.51 | -0.96 | -0.61 | |
| -1.41 | 1.13 | 1.75 | 1.57 | -0.81 | -0.06 | -0.11 | -0.02 | -0.01 | -0.47 | 0.27 | -0.26 | |
| Net Cash Flow | -0.01 | 0.86 | 1.56 | 0.10 | -0.37 | -0.88 | 0.32 | -0.21 | -0.21 | 0.23 | 0.05 | 0.64 |
| Free Cash Flow | 1.40 | -0.31 | -0.29 | -1.58 | 0.36 | -0.86 | 0.36 | -0.19 | -0.20 | 1.09 | 0.44 | -0.21 |
| CFO/OP | 188% | -18% | 106% | -309% | 250% | -129% | 108% | 0% | 59% | 173% | 96% | 177% |
Ratios
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 128.10 | 163.19 | 185.73 | 233.36 | 186.94 | 194.15 | 305.22 | 231.31 | 216.42 | 152.00 | 111.02 | 96.26 |
| Inventory Days | 50.02 | 17.78 | 6.24 | 85.34 | 82.27 | 62.14 | 45.45 | 42.45 | 70.96 | 87.18 | 105.11 | |
| Days Payable | 155.51 | 141.02 | 139.76 | 134.58 | 134.09 | 70.42 | 100.27 | 58.60 | 85.22 | 41.86 | 52.14 | |
| Cash Conversion Cycle | 22.61 | 39.94 | 52.21 | 184.13 | 135.12 | 185.86 | 305.22 | 176.49 | 200.27 | 137.74 | 156.34 | 149.23 |
| Working Capital Days | 21.76 | 30.81 | 9.24 | 158.07 | 148.07 | 188.85 | 253.22 | 200.54 | 199.54 | 153.84 | 144.01 | 142.29 |
| ROCE % | 7.70% | 11.43% | 10.76% | 5.17% | 3.76% | 3.37% | 3.61% | 3.83% | 8.31% | 8.40% | 8.26% | 4.87% |
Insights
In beta| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Inventory of Raw Materials Rs. in Lakhs |
|
|||||||||
| Increase in Median Remuneration of Employees Percentage (%) |
||||||||||
| Number of Permanent Employees Number |
||||||||||
Requires Premium
Requires Premium
Extracted by Screener AI
Documents
Announcements
-
Board Meeting Outcome for Submission Of Standalone Audited Financial Results For The Year Ended 31 March, 2026
30 May - KMS Medisurgi approved FY26 audited standalone results; revenue Rs1,220.85 lakh, net profit Rs24.55 lakh, qualified opinion.
- Submission Of Standalone Audited Financial Results For The Year Ended 31 March, 2026 30 May
-
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On May 30, 2026
25 May - Board meeting on May 30, 2026 to approve standalone audited financial results for year ended March 31, 2026.
-
Intimation Of Board Meeting To Be Held On May 30, 2026
23 May - Board meeting on May 30, 2026 to approve audited FY2026 results.
-
Announcement under Regulation 30 (LODR)-Change in Directorate
8 May - Mr. Pratik Pravin Tarpara ceased as Independent Director on 30 September 2025 after completing his first term.
Business Overview:[1]
KMSML manufactures & undertakes job work of coating of various substrates like non-woven fabrics, PU films, cotton fabrics, and taffeta silk fabrics with the adhesive. It is engaged in the business of ethical marketing and distribution of
Surgical Disposable, Haemostat, Medical
Devices, Urology Equipment, Surgery Equipment, Orthopedic /Physiotherapy Equipment, Blood Banking Equipment’s and other such Surgical Equipment in India.